Gynecologic Oncology Journal
Overview
Publication venue for
- Enhancing predictive accuracy: Assessing the laparoscopic hysterectomy readmission score in a diverse endometrial cancer population. 200:105-111. 2025
- Racial disparities in survival and molecular features among Black versus White patients with uterine serous carcinoma: An integrated study in real-world registries and legacy NRG Oncology/Gynecologic Oncology Group clinical trials. 190:S123-S125. 2024
- Prognostic biomarker validation in high grade serous carcinoma with the ovarian tumor tissue analysis consortium and the multidisciplinary ovarian cancer outcomes group. 190:S438-S440. 2024
- Trends in specific procedures performed at the time of cytoreduction for ovarian cancer: Is interval debulking surgery truly less radical? A Memorial Sloan Kettering Cancer Center Team Ovary study. 187:80-84. 2024
- Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials. 183:103-114. 2024
- Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer (Retracted Article). 183:78-84. 2024
- Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes. 184:31-42. 2024
- Association between area deprivation index and human papillomavirus vaccination status among postpartum patients. 176:S217-S218. 2023
- Disparate progress in ovarian cancer survival highlights opportunities for improved equity in cancer care. 176:S210-S211. 2023
- Into the future: A pilot study combining imaging with molecular profiling to predict resectability in ovarian cancer. 166:508-514. 2022
- Do US Screening Guidelines Contribute to Higher Stage and Worse Survival in our Youngest and Oldest Cervical Cancer Patients?. 166:S14-S16. 2022
- Impact of COVID-19 on gynecologic oncology patients: an SGO COVID-19 and Gynecologic Cancer Registry study. 166:S34-S34. 2022
- Paper Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. 166:90-99. 2022
- The impact of age and stage on the competing risk of cancer-related and non-cancer death in low- or high-grade endometrioid endometrial carcinoma and uterine serous carcinoma. 162:S293-S294. 2021
Research
Category
- OBSTETRICS & GYNECOLOGY Category
- ONCOLOGY Category
Identity
International Standard Serial Number (ISSN)
- 0090-8258